668
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Are doctors using more preventive medication for cardiovascular disease? A Swedish cross-sectional study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 297-305 | Received 18 Jul 2022, Accepted 05 Jul 2023, Published online: 19 Jul 2023

References

  • Mackenbach JP. The persistence of health inequalities in modern welfare states: the explanation of a paradox. Soc Sci Med. 2012;75(4):761–769. doi: 10.1016/j.socscimed.2012.02.031.
  • Enroth L, Jasilionis D, Németh L, et al. Changes in socioeconomic differentials in old age life expectancy in four nordic countries: the impact of educational expansion and education-specific mortality. Eur J Ageing. 2022;19(2):161–173. doi: 10.1007/s10433-022-00698-y.
  • Folkhälsans utveckling – årsrapport 2022.pdf. [Internet]. [cited 2023 Mar 17]. Available from: https://www.folkhalsomyndigheten.se/contentassets/c8374b60c7174b2592ba7f76f52c3165/folkhalsans-utveckling-arsrapport-2022.pdf.
  • Wastesson JW, Fors S, Parker MG, et al. Inequalities in health care use among older adults in Sweden 1992–2011: a repeated cross-sectional study of Swedes aged 77 years and older. Scand J Public Health. 2014;42(8):795–803. doi: 10.1177/1403494814557150.
  • Agerholm J, Bruce D, Leon AP, et al. Socioeconomic differences in healthcare utilization, with and without adjustment for need: an example from Stockholm, Sweden. Scand J Public Health. 2013;41(3):318–325. doi: 10.1177/1403494812473205.
  • Wagstaff A, Van Doorslaer E, Paci P. On the measurement of horizontal inequity in the delivery of health care. J Health Econ. 1991;10(2):169–205. doi: 10.1016/0167-6296(91)90003-6.
  • Di Girolamo C, Nusselder WJ, Bopp M, et al. Progress in reducing inequalities in cardiovascular disease mortality in Europe. Heart. 2020;106(1):40–49. doi: 10.1136/heartjnl-2019-315129.
  • Wallach-Kildemoes H, Diderichsen F, Krasnik A, et al. Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study. BMC Public Health. 2012;12:610. doi: 10.1186/1471-2458-12-610.
  • Mourtzinis G, Manhem K, Kahan T, et al. Socioeconomic status affects achievement of blood pressure target in hypertension: contemporary results from the Swedish primary care cardiovascular database. Scand J Prim Health Care. 2021;39(4):519–526. doi: 10.1080/02813432.2021.2004841.
  • Ma H, Wang X, Xue Q, et al. Cardiovascular health and life expectancy among adults in the United States. Circulation. 2023;147(15):1137–1146. doi: 10.1161/CIRCULATIONAHA.122.062457.
  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice | European Heart Journal | Oxford Academic. [cited 2021 Oct 20]; Available from: https://academic-oup-com.proxy.ub.umu.se/eurheartj/article/42/34/3227/6358713.
  • Kuneinen SM, Eriksson JG, Kautiainen H, et al. The feasibility and outcome of a community-based primary prevention program for cardiovascular disease in the 21st century. Scand J Prim Health Care. 2021;39(2):157–165. doi: 10.1080/02813432.2021.1913893.
  • Rosvold EO, Bjertness E. Illness behaviour among Norwegian physicians. Scand J Public Health. 2002;30(2):125–132. doi: 10.1080/14034940210133744.
  • Isaacs AJ, Britton AR, McPherson K. Utilisation of hormone replacement therapy by women doctors. BMJ. 1995;1995;311(7017):1399–1401. doi: 10.1136/bmj.311.7017.1399.
  • Chambers R, Belcher J. Self-reported health care over the past 10 years: a survey of general practitioners. Br J Gen Pract. 1992;42:153–156.
  • Hem E, Stokke G, Tyssen R, et al. Self-prescribing among young Norwegian doctors: a nine-year follow-up study of a nationwide sample. BMC Med. 2005;3:16. doi: 10.1186/1741-7015-3-16.
  • Hughes PH, Brandenburg N, Baldwin DC, et al. Prevalence of substance use among US physicians. JAMA. 1992;267(17):2333–2339. doi: 10.1001/jama.1992.03480170059029.
  • Christie JD, Rosen IM, Bellini LM, et al. Prescription drug use and self-prescription among resident physicians. JAMA. 1998;280(14):1253–1255. doi: 10.1001/jama.280.14.1253.
  • Wachtel TJ, Wilcox VL, Moulton AW, et al. Physicians’ utilization of health care. J Gen Intern Med. 1995;10(5):261–265. doi: 10.1007/BF02599883.
  • Töyry S, Räsänen K, Seuri M, et al. Increased personal medication use among Finnish physicians from 1986 to 1997. Br J Gen Pract. 2004;3:44-46.
  • Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–952. doi: 10.1016/S0140-6736(04)17018-9.
  • Kay M, Mitchell G, Clavarino A, et al. Doctors as patients: a systematic review of doctors’ health access and the barriers they experience. Br J Gen Pract. 2008;58(552):501–508. doi: 10.3399/bjgp08X319486.
  • Fadare J, Desalu O. Self-prescription practices by Nigerian medical doctors. South Afr Fam Pract. 2014;56(5):253–257. doi: 10.1080/20786190.2014.980155.
  • Chen JY, Tse EY, Lam TP, et al. Doctors’ personal health care choices: a cross-sectional survey in a mixed public/private setting. BMC Public Health. 2008;8:183. doi: 10.1186/1471-2458-8-183.
  • Mårdby A-C, Åkerlind I, Hedenrud T. General beliefs about medicines among doctors and nurses in out-patient care: a cross-sectional study. BMC Fam Pract. 2009;10:35. doi: 10.1186/1471-2296-10-35.
  • Brenner S, Oberaigner W, Stummer H. In guidelines physicians trust? Physician perspective on adherence to medical guidelines for type 2 diabetes mellitus. Heliyon. 2020;6(8):e04803. doi: 10.1016/j.heliyon.2020.e04803.
  • Woodward M, Brindle P, Tunstall-Pedoe H. Adding social deprivation and family history to cardiovascular risk assessment-the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart [Internet]. 2006 [cited 2017 Dec 4]. Available from: http://heart.bmj.com/content/early/2006/11/07/hrt.2006.108167.
  • Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ. 2008;336(7659):1475–1482. doi: 10.1136/bmj.39609.449676.25.
  • Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the swedish national inpatient register. BMC Public Health. 2011;11:450. doi: 10.1186/1471-2458-11-450.
  • Mortensen MB, Nordestgaard BG. Comparison of five major guidelines for statin use in primary prevention in a contemporary general population. Ann Intern Med. 2018;168(2):85–92. doi: 10.7326/M17-0681.
  • Buettner C, Davis RB, Leveille SG, et al. Prevalence of musculoskeletal pain and statin use. J Gen Intern Med. 2008;23(8):1182–1186. doi: 10.1007/s11606-008-0636-7.
  • der VT, Frings-Dresen MHW, Sluiter JK. Health behaviors, care needs and attitudes towards self-prescription: a cross-sectional survey among Dutch medical students. PLoS One. 2011;6(11):e28038. doi: 10.1371/journal.pone.0028038.
  • Frank E, Dresner Y, Shani M, et al. The association between physicians’ and patients’ preventive health practices. CMAJ. 2013;185(8):649–653. doi: 10.1503/cmaj.121028.
  • Søgaard R, Diederichsen ACP, Rasmussen LM, et al. Cost effectiveness of population screening vs. no screening for cardiovascular disease: the Danish cardiovascular screening trial (DANCAVAS). Eur Heart J. 2022;43(41):4392–4402. doi: 10.1093/eurheartj/ehac488.